Paper40928697
Advances in Drug Research Targeting Neutrophils for the Treatment of Rheumatoid Arthritis.
Wang Y and 2 others. Curr Rheumatol Rep, 2025. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Advances in Drug Research Targeting Neutrophils for the Treatment of Rheumatoid Arthritis. Papers, record 40928697. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40928697
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Advances in Drug Research Targeting Neutrophils for the Treatment of Rheumatoid Arthritis.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Arthritis, Rheumatoid | Major topic |
| Antirheumatic Agents | Major topic |
| Neutrophils | Major topic |
| Extracellular Traps | Major topic |
| Humans | |
| Biological Products | |
| Drugs, Chinese Herbal |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| No.KYZZ202502 | The Hubei Enshi College School-level Key Scientific Research Project | PubMed | ||
| No.81960776 | The National Natural Science Foundation of China | PubMed | ||
| No.2023AFD069 | The Natural Science Foundation of Hubei Province | PubMed | ||
| No.D20230022 | The Technical support projects of Enshi Tujia and Miao Autonomous Prefecture Science and Technology Bureau | PubMed |
Source PubMed
References83
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31767647 | Neutrophil Extracellular Traps in Host Defense. | Cold Spring Harb Perspect Biol | 2020 | https://conductscience.org/library/papers/31767647 | PubMed |
| 2 | 35173870 | Traditional Chinese medicine together with high-dose vitamin C improves the therapeutic effect of western medicine against COVID-19. | Am J Transl Res | 2022 | https://conductscience.org/library/papers/35173870 | PubMed |
| 3 | 37938773 | Deconstruction of rheumatoid arthritis synovium defines inflammatory subtypes. | Nature | 2023 | https://conductscience.org/library/papers/37938773 | PubMed |
| 4 | 33117162 | Potential Advantages of Bioactive Compounds Extracted From Traditional Chinese Medicine to Inhibit Bone Destructions in Rheumatoid Arthritis. | Front Pharmacol | 2020 | https://conductscience.org/library/papers/33117162 | PubMed |
| 5 | 39221253 | The emerging role of neutrophil extracellular traps in the progression of rheumatoid arthritis. | Front Immunol | 2024 | https://conductscience.org/library/papers/39221253 | PubMed |
| 6 | 38576269 | Neutrophil extracellular trap formation and its implications in nonsteroidal anti-inflammatory drug-induced small intestinal injury. | J Gastroenterol Hepatol | 2024 | https://conductscience.org/library/papers/38576269 | PubMed |
| 7 | 40076593 | Neutrophils: Linking Inflammation to Thrombosis and Unlocking New Treatment Horizons. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40076593 | PubMed |
| 8 | 22980329 | Intravascular neutrophil extracellular traps capture bacteria from the bloodstream during sepsis. | Cell Host Microbe | 2012 | https://conductscience.org/library/papers/22980329 | PubMed |
| 9 | 24860732 | Anti-inflammatory and Antimicrobial Effects of Heat-Clearing Chinese Herbs: A Current Review. | J Tradit Complement Med | 2014 | https://conductscience.org/library/papers/24860732 | PubMed |
| 10 | 36132145 | Drug repurposing of ivermectin abrogates neutrophil extracellular traps and prevents melanoma metastasis. | Front Oncol | 2022 | https://conductscience.org/library/papers/36132145 | PubMed |
| 11 | 39701217 | Systematic insight into the dual COX-2/5-LOX inhibitory mechanism of Duhuo Jisheng decoction for treatment of osteoarthritis based on in silico and bioassay. | J Ethnopharmacol | 2025 | https://conductscience.org/library/papers/39701217 | PubMed |
| 12 | 39300084 | Neutrophil extracellular traps in homeostasis and disease. | Signal Transduct Target Ther | 2024 | https://conductscience.org/library/papers/39300084 | PubMed |
| 13 | 21639923 | A traditional Chinese medicine versus Western combination therapy in the treatment of rheumatoid arthritis: two-stage study protocol for a randomized controlled trial. | Trials | 2011 | https://conductscience.org/library/papers/21639923 | PubMed |
| 14 | 38812134 | [Optimization and verification of conditions for induction of neutrophil extracellular traps in vitro]. | Zhongguo Zhong Yao Za Zhi | 2024 | https://conductscience.org/library/papers/38812134 | PubMed |
| 15 | 32253838 | Use of Tripterygium wilfordii Hook F for immune-mediated inflammatory diseases: progress and future prospects. | J Zhejiang Univ Sci B | 2020 | https://conductscience.org/library/papers/32253838 | PubMed |
| 16 | 33519474 | Clinical Practice Guideline for Tripterygium Glycosides/Tripterygium wilfordii Tablets in the Treatment of Rheumatoid Arthritis. | Front Pharmacol | 2020 | https://conductscience.org/library/papers/33519474 | PubMed |
| 17 | 39105461 | Neutrophil extracellular traps: Potential targets for the treatment of rheumatoid arthritis with traditional Chinese medicine and natural products. | Phytother Res | 2024 | https://conductscience.org/library/papers/39105461 | PubMed |
| 18 | 40371029 | Quality-by-Design (QbD) Assisted Synthesis of Nanoparticle for Efficient Loading, Stabilization, and Intracellular Delivery of Bioactive for the Treatment of Arthritis. | Indian J Microbiol | 2025 | https://conductscience.org/library/papers/40371029 | PubMed |
| 19 | 27643663 | Therapeutic potential of Oroxylin A in rheumatoid arthritis. | Int Immunopharmacol | 2016 | https://conductscience.org/library/papers/27643663 | PubMed |
| 20 | 39226727 | Targeting neutrophils extracellular traps, a promising anti-thrombotic therapy for natural products from traditional Chinese herbal medicine. | Biomed Pharmacother | 2024 | https://conductscience.org/library/papers/39226727 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 41993209 | Association between neutrophil-to-lymphocyte ratio and the prognosis of patients with rheumatoid arthritis: a meta-analysis. | Front Immunol | 2026 | https://conductscience.org/library/papers/41993209 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40928697
GET https://conductscience.org/api/papers/v1/40928697/references?page=2